NCT03688503View on ClinicalTrials.gov

Magnesium Supplementation and Blood Pressure Reduction

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

February 15, 2019

Primary Completion Date

January 9, 2020

Study Completion Date

August 15, 2025

Conditions
Blood Pressure
Interventions
DIETARY_SUPPLEMENT

magnesium glycinate supplement

magnesium glycinate (480 mg/day)

DIETARY_SUPPLEMENT

placebo

placebo

Trial Locations (1)

02215

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

Pure Encapsulations

INDUSTRY

lead

Brigham and Women's Hospital

OTHER

NCT03688503 - Magnesium Supplementation and Blood Pressure Reduction | Biotech Hunter | Biotech Hunter